Methods for the design of vasomotor symptom trials: The Menopausal Strategies: Finding lasting answers to symptoms and health network

Menopause

Volumn 21, Issue 1, 2014, Pages 45-58

  Newton, Katherine M ^a   Carpenter, Janet S ^b   Guthrie, Katherine A ^c   Anderson, Garnet L ^c   Caan, Bette ^d   Cohen, Lee S ^e   Ensrud, Kristine E ^f   Freeman, Ellen W ^g   Joffe, Hadine ^e   Sternfeld, Barbara ^d   Reed, Susan D ^h   Sherman, Sheryl ⁱ   Sammel, Mary D ^g   Kroenke, Kurt ^j   Larson, Joseph C ^c   Lacroix, Andrea Z ^c  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d DIVISION OF RESEARCH   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ NATIONAL INSTITUTE ON AGING   (United States)

^j INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Clinical trial network; Exercise; Hot flashes; Menopause; Methodology; Study design; Vasomotor symptoms; Yoga

Indexed keywords

ESCITALOPRAM; ESTRADIOL; FOLLITROPIN; OMEGA 3 FATTY ACID; VENLAFAXINE;

ADULT; AFRICAN AMERICAN; ANXIETY; ARTICLE; BLOOD SAMPLING; CAUCASIAN; CLIMACTERIUM; CLINICAL DATA REPOSITORY; CONSENSUS; DEPRESSION; DIET SUPPLEMENTATION; DISEASE DURATION; DISEASE SEVERITY; DRUG COST; DRUG DOSE ESCALATION; DRUG EFFICACY; E-MAIL; EXERCISE; FACTORIAL DESIGN; FEMALE; HOT FLUSH; HUMAN; HYSTERECTOMY; LOW DRUG DOSE; MENOPAUSAL SYNDROME; MIDDLE AGED; MOOD; MULTICENTER STUDY (TOPIC); NIGHT SWEAT; OUTCOME ASSESSMENT; OVARIECTOMY; OVARY INSUFFICIENCY; PAIN; PATIENT PARTICIPATION; PATIENT SELECTION; PLACEBO EFFECT; POSTMENOPAUSE; PRACTICE GUIDELINE; PREMATURE OVARIAN FAILURE; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALIVA ANALYSIS; SCREENING TEST; SEXUAL DISTRESS; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SLEEP; STATISTICAL ANALYSIS; STRESS; STUDY DESIGN; SYMPTOM; TELEPHONE; URINALYSIS; VAGINA FLORA; VASOMOTOR DISORDER; YOGA;

BIOMEDICAL RESEARCH; CITALOPRAM; CYCLOHEXANOLS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGENS; EXERCISE THERAPY; FATTY ACIDS, OMEGA-3; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PLACEBOS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SEROTONIN UPTAKE INHIBITORS; STATISTICS AS TOPIC; SWEATING; TIME FACTORS; YOGA;

EID: 84891829011     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e31829337a4     Document Type: Article

References (59)

1. Freeman EW, Guthrie KA, Caan B, et al. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA 2011;305:267-274.
2. Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001;153:865-874.
3. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-473.
4. McKinlay S, Jefferys M, Thompson B. An investigation of the age at menopause. J Biosoc Sci 1972;4:161-173.
5. US Food and Drug Administration. Guidance for Industry: Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy SymptomsVRecommendations for Clinical Evaluation. Rockville, MD: Division of Drug Information (HDF-240), Center for Drug Evaluation and Research, 2003.
6. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-272.
7. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol 2001;19:4280-4290.
8. Newton KM, Buist DS, Keenan NL, Anderson LA, LaCroix AZ. Use of alternative therapies for menopause symptoms: results of a population based survey. Obstet Gynecol 2002;100:18-25.
9. Avis NE, Kaufert PA, Lock M, McKinlay SM, Vass K. The evolution of menopausal symptoms. Baillieres Clin Endocrinol Metab 1993;7:17-32.
10. Carpenter JS. The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 2001;22:979-989.
11. Smith MT, Wegener ST. Measure of sleep. Arthritis Rheum 2003;49: S184-S196.
12. Kroenke K, Zhong X, Theobald D, Wu J, Tu W, Carpenter JS. Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med 2010;170: 1686-1694.
13. Gilbody S, Richards D, Barkham M. Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and CORE-OM. Br J Gen Pract 2007;57:650-652.
14. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med 2007;22:1596-1602.
15. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974;19:1-15.
16. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry 1974;7:79-110.
17. Lipman RS, Covi L, Shapiro AK. The Hopkins Symptom Checklist (HSCL)Vfactors derived from the HSCL-90. J Affect Disord 1979;1:9-24.
18. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-396.
19. Krebs EE, Lorenz KA, Bair MJ, et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med 2009;24:733-738.
20. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-138.
21. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004;5:133-137.
22. Hilditch JR, Lewis J, Peter A, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24:161-175.
23. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993;29:321-326.
24. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
25. Derogatis L, Clayton A, Lewis-Dagostino D, Wunderlich G, Fu Y. Validation of the Female Sexual Distress ScaleVRevised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 2008;5:357-364.
26. Newton K, LaCroix A, Leveille S, Rutter C, Keenan N, Anderson L. Womens beliefs and decisions about hormone replacement therapy. J Womens Health 1997;6:459-465.
27. Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297-307.
28. Smith S, Trinder J. Detecting insomnia: comparison of four self-report measures of sleep in a young adult population. J Sleep Res 2001;10:229-235.
29. Morin C. Insomnia: Psychological Assessment and Management. New York, NY: Guilford Press, 1993.
30. Morin CM, Vallieres A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA 2009;301:2005-2015.
31. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999;281:991-999.
32. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
33. Carpenter JS, AndrykowskiMA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 1998;45:5-13.
34. Buysse DJ, Germain A, Moul DE, et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med 2011; 171:887-895.
35. de Souza L, Benedito-Silva AA, Pires ML, Poyares D, Tufik S, Calil HM. Further validation of actigraphy for sleep studies. Sleep 2003;26:81-85.
36. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003;26:342-392.
37. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 2006;63:385-390.
38. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62-70.
39. Krebs EE, Bair MJ, Damush TM, Tu W, Wu J, Kroenke K. Comparative responsiveness of pain outcome measures among primary care patients with musculoskeletal pain. Med Care 2010;48:1007-1014.
40. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983;17:197-210.
41. Hann DM, Jacobsen PB, Azzarello LM, et al. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res 1998;7:301-310.
42. Carpenter JS, Storniolo AM, Johns S, et al. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 2007;12:124-135.
43. Elkins G, Marcus J, Stearns V, Hasan Rajab M. Pilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivors. Psychooncology 2007;16:487-492.
44. Suvanto-Luukkonen E, Koivunen R, Sundstrom H, et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 2005;12:18-26.
45. Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002;20:1578-1583.
46. Loprinzi L, Barton DL, Sloan JA, et al. Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc 2002;77:1159-1163.
47. Pruthi S, Qin R, Terstreip SA, et al. A phase III, randomized, placebocontrolled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause 2012;19:48-53.
48. Bootzin RR. The role of expectancy in behavior change. In: White L, Turskey B, Schwartz G, eds. Placebo: Theory, Research and Mechanisms. New York, NY: Guilford Press, 1985:196-210.
49. Gross D. On the merits of attention-control groups. Res Nurs Health 2005;28:93-94.
50. Srinivasan S, Liu C, Mitchell CM, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS ONE 2010;5:e10197.
51. Carpenter JS, Andrykowski MA, Freedman RR, Munn R. Feasibility and psychometrics of an ambulatory hot flash monitoring device. Menopause 1999;6:209-215.
52. Carpenter JS, Monahan PO, Azzouz F. Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring. Obstet Gynecol 2004;104:1322-1326.
53. Thurston RC, Blumenthal JA, Babyak MA, Sherwood A. Emotional antecedents of hot flashes during daily life. Psychosom Med 2005; 67:137-146.
54. Carpenter JS, Newton KM, Sternfeld B, et al. Laboratory and ambulatory evaluation of vasomotor symptom monitors from the Menopause Strategies Finding Lasting Answers for Symptoms and Health network. Menopause 2012;19:664Y671.
55. Anderson GL, Prentice RL. Individually randomized intervention trials for disease prevention and control. Stat Methods Med Res 1999;8:287-309.
56. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31:103-115.
57. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials 3rd ed. New York, NY: Springer-Verlag, 1998.
58. Vickers AJ. The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study. BMC Med Res Methodol 2001;1:6.
59. Sood R, Sood A, Wolf SL, et al. Paced breathing compared with usual breathing for hot flashes. Menopause 2013;20:179-184.